Your Article Summary
See Latest ArticlesConcurrent validity of the PSYCH-6, a very short scale for detecting anxiety and depression, among oncology outpatients
Australian and New Zealand Journal of Psychiatry, 06/22/09
Clover K et al. - The PSYCH-6 scale of the SPHERE-12 at a cut-off point of 3 is an equivalent instrument to the HADS-T for detecting cases and excluding non-cases of anxiety and depression and is suitable for deployment in oncology populations.
Methods- Cross-sectional survey of 340 oncology outpatients attending a regional hospital in Newcastle, Australia.
- The performance of the PSYCH-6 against the Hospital Anxiety and Depression Scale (HADS) was evaluated using correlation, Cohen's kappa, positive agreement and negative agreement.
- The PSYCH-6 subscale of the SPHERE-12, at a cut-off point of 3, had substantial agreement with the total score of the HADS (HADS-T; κ = 0.73, p < 0.001).
- Negative agreement (0.92) was marginally higher than positive agreement (0.80).
Related Articles
Anxiety and depressive disorders in offspring at high risk for anxiety: A meta-analysis
Journal of Anxiety Disorders, 11/19/09
Relevance Score: 69%
Validation of the Hospital Anxiety and Depression Scale for use with multiple sclerosis patients
Multiple Sclerosis, 11/18/09
Relevance Score: 69%
Anxiety and depression during pregnancy in women and men
Journal of Affective Disorders, 11/13/09
Relevance Score: 69%
Relationships of Fear, Anxiety, and Depression With Physical Function in Patients With Knee Osteoarthritis
Archives of Physical Medicine and Rehabilitation, 11/06/09
Relevance Score: 69%
Gender as a determinant of responses to a self-screening questionnaire on anxiety and depression by patients with coronary artery disease
Gender Medicine, 10/23/09
Relevance Score: 69%
Today in Side Effects...keeping you current
Receive free subspecialty "5-minute updates" via email
Immunoglobulin G Fc Receptor FcgammaRIIIa 158 V/F Polymorphism Correlates With Rituximab-Induced Neutropenia After Autologous Transplantation in Patients With Non-Hodgkin's Lymphoma
Journal of Clinical Oncology, 12/04/09
Cytidine Deaminase Residual Activity in Serum Is a Predictive Marker of Early Severe Toxicities in Adults After Gemcitabine-Based Chemotherapies
Journal of Clinical Oncology, 12/04/09
Hepatic Toxicities Associated with the Use of Preoperative Systemic Therapy in Patients with Metastatic Colorectal Adenocarcinoma to the Liver
The Oncologist, 12/03/09